Morrow Z, Sauer J
Infect Immun. 2023; 91(7):e0054022.
PMID: 37306593
PMC: 10353425.
DOI: 10.1128/iai.00540-22.
Pal S, Sheff S, Al-Kuhlani M, Ojcius D, de la Maza L
Microbiol Spectr. 2022; 10(4):e0161722.
PMID: 35876584
PMC: 9431660.
DOI: 10.1128/spectrum.01617-22.
Sag D, Ayyildiz Z, Gunalp S, Wingender G
Cancers (Basel). 2019; 11(10).
PMID: 31574961
PMC: 6826877.
DOI: 10.3390/cancers11101469.
Zhu Q, Man S, Karki R, Malireddi R, Kanneganti T
Cell Rep. 2018; 22(12):3168-3174.
PMID: 29562174
PMC: 6204211.
DOI: 10.1016/j.celrep.2018.02.096.
McDougal C, Sauer J
Pathogens. 2018; 7(1).
PMID: 29324702
PMC: 5874734.
DOI: 10.3390/pathogens7010008.
Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearance.
Gyurkovska V, Ivanovska N
Inflamm Res. 2016; 65(6):427-37.
PMID: 26943649
DOI: 10.1007/s00011-016-0934-1.
A physical/psychological and biological stress combine to enhance endoplasmic reticulum stress.
Mondal T, Emeny R, Gao D, Ault J, Kasten-Jolly J, Lawrence D
Toxicol Appl Pharmacol. 2015; 289(2):313-22.
PMID: 26391182
PMC: 4651807.
DOI: 10.1016/j.taap.2015.09.013.
Therapeutic applications of TRAIL receptor agonists in cancer and beyond.
Amarante-Mendes G, Griffith T
Pharmacol Ther. 2015; 155:117-31.
PMID: 26343199
PMC: 4955572.
DOI: 10.1016/j.pharmthera.2015.09.001.
Crucial roles of TNFAIP8 protein in regulating apoptosis and Listeria infection.
Porturas T, Sun H, Buchlis G, Lou Y, Liang X, Cathopoulis T
J Immunol. 2015; 194(12):5743-50.
PMID: 25948813
PMC: 4458408.
DOI: 10.4049/jimmunol.1401987.
Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity.
Eshleman E, Lenz L
Front Immunol. 2014; 5:431.
PMID: 25309533
PMC: 4161047.
DOI: 10.3389/fimmu.2014.00431.
The C5a anaphylatoxin receptor (C5aR1) protects against Listeria monocytogenes infection by inhibiting type 1 IFN expression.
Calame D, Mueller-Ortiz S, Morales J, Wetsel R
J Immunol. 2014; 193(10):5099-107.
PMID: 25297874
PMC: 4295506.
DOI: 10.4049/jimmunol.1401750.
Switching off key signaling survival molecules to switch on the resolution of inflammation.
Perez D, Vago J, Athayde R, Reis A, Teixeira M, Sousa L
Mediators Inflamm. 2014; 2014:829851.
PMID: 25136148
PMC: 4127222.
DOI: 10.1155/2014/829851.
Confounding roles for type I interferons during bacterial and viral pathogenesis.
Carrero J
Int Immunol. 2013; 25(12):663-9.
PMID: 24158954
PMC: 3839063.
DOI: 10.1093/intimm/dxt050.
TRAIL receptor deficiency sensitizes mice to dextran sodium sulphate-induced colitis and colitis-associated carcinogenesis.
Zhu J, Chen L, Shi J, Liu S, Liu Y, Zheng D
Immunology. 2013; 141(2):211-21.
PMID: 24117005
PMC: 3904242.
DOI: 10.1111/imm.12181.
Age-dependent differences in systemic and cell-autonomous immunity to L. monocytogenes.
Sherrid A, Kollmann T
Clin Dev Immunol. 2013; 2013:917198.
PMID: 23653659
PMC: 3638699.
DOI: 10.1155/2013/917198.
TRAIL: not just for tumors anymore?.
Benedict C, Ware C
J Exp Med. 2012; 209(11):1903-6.
PMID: 23091198
PMC: 3478931.
DOI: 10.1084/jem.20122235.
TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice.
Steinwede K, Henken S, Bohling J, Maus R, Ueberberg B, Brumshagen C
J Exp Med. 2012; 209(11):1937-52.
PMID: 23071253
PMC: 3478925.
DOI: 10.1084/jem.20120983.
Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunity.
Zhang Y, Zhang R, Zhang H, Liu J, Yang Z, Xu P
Cell Mol Immunol. 2012; 9(6):489-96.
PMID: 23064105
PMC: 4002214.
DOI: 10.1038/cmi.2012.33.
Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections.
Kearney S, Delgado C, Lenz L
Immunol Res. 2012; 55(1-3):187-200.
PMID: 22983898
PMC: 3926967.
DOI: 10.1007/s12026-012-8362-y.
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics.
Dimberg L, Anderson C, Camidge R, Behbakht K, Thorburn A, Ford H
Oncogene. 2012; 32(11):1341-50.
PMID: 22580613
PMC: 4502956.
DOI: 10.1038/onc.2012.164.